UPDATED: After delays, Sarepta’s DMD gene therapy Elevidys finally crosses FDA finish line at $3.2M zbecker Thu, 06/22/2023 – 12:26 More: UPDATED: After delays, Sarepta's DMD gene therapy Elevidys finally crosses FDA finish line at .2M Source: fierce
read moreNovo Nordisk, Eli Lilly face scrutiny from EU’s drug regulator over GLP-1 safety kdunleavy Thu, 06/22/2023 – 11:02 More: Novo Nordisk, Eli Lilly face scrutiny from EU's drug regulator over GLP-1 safety Source: fierce
read moreIntercept restructures as Ocaliva’s NASH hopes dashed again with FDA rejection aliu Thu, 06/22/2023 – 10:37 More: Intercept restructures as Ocaliva's NASH hopes dashed again with FDA rejection Source: fierce
read moreAldeyra’s eye cancer hopes dashed as FDA issues rejection citing lack of clinical data zbecker Thu, 06/22/2023 – 09:14 More: Aldeyra's eye cancer hopes dashed as FDA issues rejection citing lack of clinical data Source: fierce
read morePfizer, GSK RSV shots get tepid recommendations from CDC advisory panel kdunleavy Thu, 06/22/2023 – 07:42 More: Pfizer, GSK RSV shots get tepid recommendations from CDC advisory panel Source: fierce
read morePoolbeg’s platform will possess the capability to generate vaccines for a wide range of diseases More: Poolbeg progress oral vaccine programme Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals